PubMed
Peptide bioregulators: a new class of geroprotectors
Khavinson et al., 2006
Longevity & Anti-AgingResearch OnlyB
Pinealon
EDR Peptide
Russian peptide-bioregulator discussed for cognitive and aging-related signaling.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 5
- Research grade
- B
- Experience
- 57
- Activity
- 91
Overall check-ins
Trackers & reports
Overview
About Pinealon
Russian peptide-bioregulator discussed for cognitive and aging-related signaling.
- Category
- Longevity & Anti-Aging
- Regulatory status
- Research Only
- Also known as
- EDR Peptide
- Self-reports
- 20
Community
What 20 users report
20 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 3% · Mixed 97% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Cognition
145
Recovery
145
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Injection site irritation
140
Self-reported dose per injection
Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg
Reports span 0.1 to ≥ 2 mg (open-ended top bucket)
0.1–0.2 mg
31
0.2–0.4 mg
107
1–2 mg
5
2+ mg
2
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 72% said they felt similar to their last entry, 28% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 105 days · Based on 18 repeat reporters
Research
Cited research (4)
Source
PubMed
Peptide bioregulation of aging: results and prospects
Khavinson, 2009
PubMed
Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes
Khavinson et al., 2011
PubMed
EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease
Khavinson et al., 2020
Tools
Explore more
Explore
More ways to learn about Pinealon from observational PeptIQ data.
Related peptides
Help
Frequently asked
What do PeptIQ users report about Pinealon?
This page summarizes 20 anonymized self-reports from PeptIQ users who track Pinealon, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for Pinealon?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for Pinealon?
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is Pinealon safe to use?
This wiki does not assess safety or recommend use. Pinealon is listed as Research Only. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of Pinealon?
Research, primarily in animal models, suggests Pinealon may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of Pinealon?
Pinealon is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Pinealon as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of Pinealon?
The safety and effectiveness of Pinealon have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on Pinealon?
While there are over 200 published studies on Pinealon, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source